By outsourcing with ClinCore, our partners can save up to 60% by capitalizing on the government of Australia’s R&D tax incentives. This will lead to a substantial increase in profit margins for our partners by procuring low-cost infrastructure and manpower. Outsourcing will reduce overhead expenses as well as excessive and unnecessary expenditures may be reduced. This amount saved may be reinvested in further R&D for ultimately improving patients’ quality of life.
Apart from the evident financial gains, outsourcing will provide pharmaceutical companies with access to highly skilled professionals who are ready to undertake clinical responsibilities and tasks of varying complexity.
Outsourcing studies also provide access to large patient bases as access to patients has become increasingly difficult with time.